Papillary Carcinoma, postoperative, follow-up
Showing 1 - 25 of >10,000
Asymptomatic Papillary Microcarcinomas on Patient Survival
Active, not recruiting
- Papillary Carcinoma
- Questionnaire
-
Toulouse, FranceUHToulouse
May 15, 2023
Cross-sectional Case and Control Study on Quality of Life,
Recruiting
- Papillary Thyroid Carcinoma
- Thyroid Cancer
- Thyroid lobectomy via trans-axillary approach
- Thyroid lobectomy via open approach
-
Beijing, Beijing, ChinaDepartment of General Surgery, Peking Union Medical College Hosp
Jul 5, 2023
Cohort Study in Intraductal Papillary Mucinous Neoplasm
Not yet recruiting
- IPMN, Pancreatic
- Endoscopic ultrasound
- (no location specified)
Nov 10, 2022
Thyroglobulin and Galectin-3 for Prognosis and Follow-up in
Recruiting
- Thyroid Cancer
- +2 more
-
Taipei, TaiwanChih-Yuan Wang, M.D
Oct 16, 2022
Head and Neck Squamous Cell Carcinoma, PET/CT Trial (Neck dissection)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- PET/CT
- Neck dissection
- (no location specified)
Jan 31, 2023
EVeRLAST 2-Year Follow-Up
Not yet recruiting
- Pelvic Organ Prolapse
- Expedited postoperative activity instructions
- Standard postoperative activity restructions
- (no location specified)
Sep 13, 2022
Surgery, Postoperative Cognitive Dysfunction Trial in Hasselt (neurocognitive test battery)
Recruiting
- Surgery
- Postoperative Cognitive Dysfunction
- neurocognitive test battery
-
Hasselt, Limburg, BelgiumJessa Hospital
Nov 22, 2022
Cancer Patients' Diagnostic and Management: Set-up of Indicators
Recruiting
- Hepatocellular Carcinoma
- Peritoneal Carcinoma
- COLLAT-COVID is an observational study based on retrospective data issued from patients medial files.
-
Pierre-Bénite, FranceHopital Lyon sud, Hospices civils de Lyon
Jul 7, 2023
High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai (ctDNA
Recruiting
- High-risk Stage II Colorectal Cancer
- +2 more
- ctDNA methylation dynamic monitoring
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jun 14, 2023
Head and Neck Squamous Cell Carcinoma Trial in Villejuif (Nasofibroscopy, Low Dose Chest CTscan, injected CT-scan)
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- Nasofibroscopy
- +5 more
-
Villejuif, Val De Marne, FranceGustave Roussy
Jan 19, 2023
Cancer Survivor, Prostate Carcinoma Trial in Duarte (Educational Intervention, Laboratory Biomarker Analysis, Long-term
Active, not recruiting
- Cancer Survivor
- Prostate Carcinoma
- Educational Intervention
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 31, 2023
Follow up After TACE by Elastography and Color Doppler.
Not yet recruiting
- Hepatocellular Carcinoma
- US
- (no location specified)
Oct 2, 2023
Small Cell Lung Cancer Limited Stage Trial (Prophylactic cranial irradiation, Thoracic radiotherapy, Chemotherapy)
Not yet recruiting
- Small Cell Lung Cancer Limited Stage
- Prophylactic cranial irradiation
- +2 more
- (no location specified)
Dec 14, 2022
Follow-up in People With Basal Cell Carcinoma
Not yet recruiting
- Basal Cell Carcinoma
- Digital Dermoscopy
- +4 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Jul 21, 2022
Follow-up of High-risk Population of PDAC Based on EUS
Not yet recruiting
- Carcinoma, Pancreatic Ductal
- Endoscopic ultrasound
- EUS-Fine needle aspiration
- (no location specified)
Nov 18, 2022
Renal Cell Carcinoma Metastatic Trial in France (KidneyPRO, standard follow-up)
Recruiting
- Renal Cell Carcinoma Metastatic
- KidneyPRO
- standard follow-up
-
Angers, France
- +12 more
May 2, 2022
Cervical Carcinoma Trial in Philadelphia (Health Promotion and Education, Survey Administration, Interview)
Completed
- Cervical Carcinoma
- Health Promotion and Education
- +2 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Dec 13, 2022
Hysterectomy, Genital Diseases, Female, Pain Trial in Sweden (Follow-up strategy, No contact after discharge)
Completed
- Hysterectomy
- +2 more
- Follow-up strategy
- No contact after discharge
-
Eksjo, Jonkopings Län, Sweden
- +4 more
Feb 4, 2022
Relapse in Esophageal Squamous Cell Cancers Who Achieve PCR to
Active, not recruiting
- Esophageal Cancer
- follow up
-
Guangzhou, Guangdong, ChinaJianhua Fu
Sep 24, 2023
Stage III NSCLC Trial (18F FDG PET/CT, CT scan)
Not yet recruiting
- Stage III Non-small Cell Lung Cancer
- 18F FDG PET/CT
- CT scan
- (no location specified)
Oct 9, 2023
UCAD for Diagnosing Benign or Malignant Biliary Obstruction and
Recruiting
- Biliary Tract Neoplasms
- +3 more
- The level of CIN
-
Shanghai, Shanghai, ChinaXinhua Hospital
Jan 12, 2023
Subjects Previously Enrolled on NCI Surgery Branch Studies
Enrolling by invitation
- Melanoma
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 18, 2022
Small Early Liver Cancer With Natural History Follow up
Recruiting
- Hepatocellular Carcinoma
- Blood & Urine Samples
- Imaging
-
Oxford, Oxfordshire, United KingdomHepatology Clinical Trial Unit, John Radcliffe Hospital
Sep 5, 2022
Non-Small-Cell Lung Carcinoma Trial in France (Radiological Arm, Scannographic arm)
Completed
- Non-Small-Cell Lung Carcinoma
- Radiological Arm
- Scannographic arm
-
Belfort, France
- +6 more
Aug 9, 2022
Patients' Whole Process Follow-up Management
Recruiting
- Locally Advanced Non-Small Cell Lung Cancer
- Metastatic NSCLC
- Patients' whole process follow-up and management platform
-
Jinan, Shandong, ChinaThe First Affiliated Hospital of Shandong First Medical Universi
Sep 5, 2022